noncontiguous stage II small lymphocytic lymphoma
Showing 9976 - 10000 of >10,000
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial
Recruiting
- Fallopian Tube Endometrioid Adenocarcinoma
- +32 more
- Carboplatin
- +6 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 16, 2022
Locally Advanced Head and Neck Carcinoma Trial in Grenoble, Lyon, Saint-Étienne (Blood sample)
Not yet recruiting
- Locally Advanced Head and Neck Carcinoma
- Blood sample
-
Grenoble, France
- +2 more
Jan 24, 2023
Malignant Tumor Trial in Tainan, Taipei (NBM-BMX softgel capsules)
Completed
- Malignant Neoplasm
- NBM-BMX softgel capsules
-
Tainan, Taiwan
- +1 more
Apr 11, 2022
Prostate Carcinoma Trial in Salt Lake City (Massage Therapy, Questionnaire Administration, Sham Intervention)
Recruiting
- Prostate Carcinoma
- Massage Therapy
- +2 more
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
May 16, 2022
Locally Advanced Unresectable Primary Central Chondrosarcoma, Metastatic Primary Central Chondrosarcoma, Unresectable Primary
Suspended
- Locally Advanced Unresectable Primary Central Chondrosarcoma
- +2 more
- Belinostat
- +5 more
-
Phoenix, Arizona
- +38 more
Feb 2, 2023
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +44 more
- Biopsy
- +23 more
-
Birmingham, Alabama
- +166 more
Feb 2, 2023
Knee Osteoarthritis Trial in Milan (Acceptance and Commitment-based treatment, Treatment as usual)
Recruiting
- Knee Osteoarthritis
- Acceptance and Commitment-based treatment
- Treatment as usual
-
Milan, ItalyAuxologico Mosè Bianchi
Mar 3, 2023
Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Cancer Trial in Tampa (Pembrolizumab, Lenvatinib)
Active, not recruiting
- Neuroendocrine Tumors
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023
Cannabis, Alcohol Effect, Driving Under the Influence of Alcohol and Other Drugs Trial in West Haven (Active inhaled cannabis,
Active, not recruiting
- Cannabis
- +2 more
- Active inhaled cannabis
- +2 more
-
West Haven, ConnecticutBiological Studies Unit, VA Connecticut Healthcare System
Jan 24, 2023
Neuroendocrine Tumors, Carcinoma, Small Cell Lung, Neuroendocrine Carcinoma Trial in United Kingdom, United States (PEN-221)
Completed
- Neuroendocrine Tumors
- +2 more
-
Fort Myers, Florida
- +12 more
Nov 16, 2021
Relapsed or Refractory Peripheral T Cell Lymphoma Trial in Worldwide (AZD4205)
Recruiting
- Relapsed or Refractory Peripheral T Cell Lymphoma
-
New Haven, Connecticut
- +50 more
Jan 27, 2022
Cerebral Small Vessel Disease Trial in Hong Kong (Exenatide extended release)
Recruiting
- Cerebral Small Vessel Disease
- Exenatide extended release
-
Hong Kong, Hong KongChinese University of Hong Kong
Jul 18, 2022
Metastatic Pancreatic Cancer Trial in Montreal (Salmonella-IL2, FOLFIRINOX Alone (Historical Controls), Gemcitabine/Abraxane
Recruiting
- Metastatic Pancreatic Cancer
- Salmonella-IL2
- +2 more
-
Montreal, Quebec, CanadaSegal Cancer Centre/ Mortimer B. Davis-Jewish General Hosptial
May 3, 2022
Advanced Cancer Trial in New Orleans, Detroit (4-Demethyl-4-cholesteryloxycarbonylpenclomedine)
Completed
- Advanced Cancer
-
New Orleans, Louisiana
- +2 more
Nov 3, 2022
Post Operative Pain Trial in Sohag (Standard anesthesia in addition to serratus plane block, Standard anesthesia in addition to
Completed
- Post Operative Pain
- Standard anesthesia in addition to serratus plane block
- Standard anesthesia in addition to para-vertebral block
-
Sohag, EgyptFaculty of Medicine, Sohag University
Mar 28, 2022
Postoperative Analgesia Trial in Cairo (Erector spinae block using bupivacaine 0.25% and magnesium sulfate, Erector spinae block
Completed
- Postoperative Analgesia
- Erector spinae block using bupivacaine 0.25% and magnesium sulfate
- Erector spinae block using bupivacaine and dememdetomidine
-
Cairo, EgyptAin Shams university
Feb 1, 2023
Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia Trial in Aurora, Columbus (PF-04449913)
Completed
- Adult Acute Myeloid Leukemia in Remission
- Recurrent Adult Acute Myeloid Leukemia
-
Aurora, Colorado
- +1 more
Dec 30, 2021
Metastatic NSCLC Trial in Worldwide (Volrustomig, Pembrolizumab, Carboplatin)
Not yet recruiting
- Metastatic Non-small Cell Lung Cancer
- Volrustomig
- +4 more
-
Rosario, Argentina
- +51 more
Aug 2, 2023
Breast Cancer Trial in Nijmegen (Vacuum assisted biopsy, conventional lumpectomy)
Recruiting
- Breast Cancer
- Vacuum assisted biopsy
- conventional lumpectomy
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Sep 20, 2021
Cardiovascular Diseases Trial in Nassau (Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))
Recruiting
- Cardiovascular Diseases
- Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
-
Nassau, The Bahamas, BahamasThe Partners Clinical Research Centre at The Medical Pavilion
Oct 17, 2023
Squamous NSCLC, Non-Squamous NSCLC Trial (Durvalumab, Tremelimumab)
Withdrawn
- Squamous Non-small Cell Lung Cancer
- Non-Squamous Non-small Cell Lung Cancer
- (no location specified)
Dec 17, 2021
Motion Sickness Trial in Fort Rucker (Osteopathic Manipulative Treatment, Sham treatment)
Completed
- Motion Sickness
- Osteopathic Manipulative Treatment
- Sham treatment
-
Fort Rucker, AlabamaUS Army Aeromedical Research Laboratory
Nov 7, 2022
Drone Biological Samples Transport vs Walking
Enrolling by invitation
- Healthy
- Biological samples transport and analysis
-
Caen, FranceChu Caen Normandie
Jul 20, 2023
Osteonecrosis of the Femoral Head Trial (Core decompression/PREOB® implantation, Core decompression/ implantation)
Terminated
- Osteonecrosis of the Femoral Head
- Core decompression/PREOB® implantation
- Core decompression/placebo implantation
- (no location specified)
Jun 17, 2022
Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis Trial (Hyperoxia)
Not yet recruiting
- Interstitial Lung Disease
- +4 more
- Hyperoxia
- (no location specified)
Nov 1, 2022